$ Value
$0
Shares
14,063
Price
$0
Filed
May 16
Insider
Name
Colangelo Dominick
Title
President and CEO
CIK
0001313403
Roles
Transaction Details
Transaction Date
2025-05-15
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). | The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024. | 6.25% of these options, representing the right to purchase a total of 90,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continued to vest in equal quarterly installments from August 8, 2017, contingent upon continued service to the Company. | These options, which were awarded on May 22, 2017, would otherwise expire and become forfeitable on May 22, 2027.
Filing Info
Colangelo Dominick's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-24 | VCEL | M | — |
| 2026-02-24 | VCEL | M | $0 |
| 2026-02-24 | VCEL | F | $336K |
| 2026-02-24 | VCEL | M | — |
| 2026-02-24 | VCEL | M | — |
| 2026-02-19 | VCEL | A | $0 |
| 2026-02-19 | VCEL | A | $0 |
| 2026-02-18 | VCEL | M | — |
| 2026-02-18 | VCEL | M | $0 |
| 2026-02-18 | VCEL | F | $212K |
Other Insiders at VCEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MCLAUGHLIN KEVIN F | — | $243K | 2026-02-11 |
|
Colangelo Dominick
President and CEO
|
— | — | 2026-02-24 |
| Rubino Alan L | — | — | 2026-03-25 |
| Hagen Heidi | — | $486K | 2026-03-23 |
|
Hopper Jonathan Mark
Chief Medical Officer
|
— | $122K | 2026-04-02 |
|
Halpin Michael
Chief Operating Officer
|
— | $364K | 2026-03-02 |
|
Flynn Sean C.
Chief Legal Officer
|
— | $754K | 2026-03-02 |
|
Mara Joseph Anthony Jr
Chief Financial Officer
|
— | — | 2026-02-24 |
|
SIEGAL JONATHAN
Principal Accounting Officer
|
— | — | 2026-02-24 |